HLA-G expression and role in advanced-stage classical Hodgkin lymphoma

https://doi.org/10.4081/ejh.2016.2606

Authors

  • G. Caocci University of Cagliari, Italy.
  • M. Greco University of Cagliari, Italy.
  • D. Fanni | fandan73@yahoo.it University of Cagliari, Italy.
  • G. Senes University of Cagliari, Italy.
  • R. Littera University of Cagliari, Italy.
  • S. Lai University of Cagliari, Italy.
  • P. Risso University of Genoa, Italy.
  • C. Carcassi University of Cagliari, Italy.
  • G. Faa University of Cagliari, Italy.
  • G. La Nasa University of Cagliari, Italy.

Abstract

Non-classical human leucocyte antigen (HLA)-G class I molecules have an important role in tumor immune escape mechanisms. We investigated HLA-G expression in lymphonode biopsies taken from 8 controls and 20 patients with advanced-stage classical Hodgkin lymphoma (cHL), in relationship to clinical outcomes and the HLA-G 14-basepair (14-bp) deletion-insertion (del-ins) polymorphism. Lymphnode tissue sections were stained using a specific murine monoclonal HLA-G antibody. HLA-G protein expression was higher in cHL patients than controls. In the group of PET-2 positive (positron emission tomography carried out after 2 cycles of standard chemotherapy) patients with a 2-year progression-free survival rate (PFS) of 40%, we observed high HLA-G protein expression within the tumor microenvironment with low expression on Hodgkin and Reed-Sternberg (HRS) cells. Conversely, PET-2 negative patients with a PFS of 86% had higher HLA-G protein expression levels on HRS cells compared to the microenvironment. Lower expression on HRS cells was significantly associated with the HLA-G 14-bp ins/ins genotype. These preliminary data suggest that the immunohistochemical pattern of HLA-G protein expression may represent a useful tool for a tailored therapy in patients with cHL, based on the modulation of HLA-G expression in relation to achievement of negative PET-2.These preliminary data suggest that the immunohistochemical pattern of HLA-G protein expression may represent a useful tool for a tailored therapy in patients with cHL, based on the modulation of HLA-G expression in relation to achievement of negative PET-2.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2016-04-11
Info
Issue
Section
Brief Reports
Keywords:
HLA-G, Hodgkin lymphoma, PET, NK cells, HRS cells.
Statistics
  • Abstract views: 1019

  • PDF: 394
  • HTML: 216
How to Cite
Caocci, G., Greco, M., Fanni, D., Senes, G., Littera, R., Lai, S., Risso, P., Carcassi, C., Faa, G., & La Nasa, G. (2016). HLA-G expression and role in advanced-stage classical Hodgkin lymphoma. European Journal of Histochemistry, 60(2). https://doi.org/10.4081/ejh.2016.2606

Most read articles by the same author(s)

1 2 > >>